Facebook Linkedin RSS Twitter Youtube
Home 2024

Viral vector (Applied microbiology)

A Solution to Industry’s Lentiviral Vector Challenge?
Bioprocessing

A Solution to Industry’s Lentiviral Vector Challenge?

Adapting a Replication-Competent AAV Assay for Commercial Manufacturing
Insights

Adapting a Replication-Competent AAV Assay for Commercial Manufacturing

Analytics Key to AV and AAV Manufacturing
Bioprocessing

Analytics Key to AV and AAV Manufacturing

Switching Gene Therapy On and Off with a Pill
Genome Editing

Switching Gene Therapy On and Off with a Pill

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy
Drug Discovery

Neurodegeneration Due to Ultra-Rare Disease Slowed by AAV Gene Therapy

Overcoming Viral Vector Risks
Bioprocessing

Overcoming Viral Vector Risks

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration
Drug Discovery

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration

Computer-Aided Design for Biology
Bioprocessing

Computer-Aided Design for Biology

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio for $600 Million
Bioprocessing

MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio for $600 Million

Tackling Manufacturing Failures for Viral Vectors
Bioprocessing

Tackling Manufacturing Failures for Viral Vectors

123...37Page 1 of 37

Recently Featured

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.